Dilarof
Dilarof Uses, Dosage, Side Effects, Mechanism of Action, How Long Does it Take to Work? Dilarof is a brand name. Its generic name is Roflumilast.
Introduction
Dilarof (trade name Daxas) is a phosphodiesterase 4 (PDE4) inhibitor developed by German pharmaceutical company Bayern Innovativ. It is indicated for the treatment of chronic obstructive pulmonary disease (COPD).
Uses
Dilarof is used to treat chronic obstructive pulmonary disease (COPD). It works by decreasing inflammation in the lungs, which helps reduce symptoms such as coughing and difficulty breathing.
Mechanism of Action
Dilarof works by inhibiting the enzyme phosphodiesterase-4 (PDE4), which is responsible for breaking down a substance called cyclic adenosine monophosphate (cAMP). By blocking this enzyme, Dilarof increases levels of cAMP, which helps reduce inflammation in the lungs.
How Long Does It Take To Work?
The effects of Dilarof may be seen as early as one week after beginning treatment but the full effects may take 6-8 weeks to be seen.
Absorption
Dilarof is rapidly absorbed after oral administration, with peak plasma concentrations reached 1.6-4 hours after dosing. Bioavailability is approximately 60%.
Route of Elimination
Dilarof is eliminated primarily by the kidneys, with approximately 85% of an oral dose excreted in the urine.
Dosage
The recommended oral dose of Dilarof is one 500 mcg tablet taken once per day. It should be taken with or without meals and can be taken at anytime during the day.
Administration
Dilarof is available as a tablet, and should be taken orally with a glass of water.
Side Effects
The most common side effects of Dilarof are gastrointestinal effects, including diarrhea, nausea, abdominal pain, and loss of appetite. Other side effects may include headache, depression, insomnia, and weight loss.
Toxicity
The toxic effects of Dilarof have not been thoroughly studied. Based on animal studies, high doses of Dilarof could cause damage to the liver and kidneys.
Precaution
Inform your healthcare provider if you are pregnant or planning to become pregnant, or if you are breastfeeding or planning to breastfeed. Tell your doctor about all medications you are taking, especially if you are taking other PDE4 inhibitors.
Interaction
Dilarof may interact with other drugs, including calcium channel blockers, corticosteroids, tricyclic antidepressants, narcotic pain relievers, and MAO inhibitors. It is recommended that patients taking any of these medications inform their doctor before taking Dilarof.
Disease Interaction
Dilarof may interact with certain diseases, including cardiovascular disease, diabetes, and kidney and liver disease. It is recommended that patients with any of these conditions inform their doctor before taking Dilarof.
Drug Interaction
Certain drugs may interact with Dilarof, including antidepressants, steroids, calcium channel blockers, and narcotic pain relievers. It is recommended that patients taking any of these medications inform their doctor before taking Dilarof.
Food Interaction
Dilarof may interact with certain foods, including grapefruit juice, alcohol, and high-fat meals. It is recommended that these foods be avoided while taking Dilarof.
Pregnancy Use
There is limited information available regarding the safety of Dilarof during pregnancy. It is recommended that pregnant women should not take Dilarof unless the potential benefit justifies the potential risk to the fetus.
Lactation Use
It is not known whether Dilarof is excreted in human milk. It is recommended that women who are breastfeeding should not take Dilarof unless the potential benefit justifies the potential risks.
Acute Overdose
In the case of an acute overdose, patients should contact a doctor or poison control center immediately. Symptoms of an acute overdose may include nausea, vomiting, abdominal pain, and diarrhea.
Contraindication
Dilarof should not be used in patients with known hypersensitivity to the active ingredient or any of the excipients. It should also not be used in patients with severe liver or kidney impairment or in patients taking ketoconazole.
Use Direction
Dilarof should be taken once daily with or without food. It is recommended that it should not be taken in combination with other PDE4 inhibitors.
Storage Condition
Dilarof tablets should be stored at a temperature between 15°C and 25°C and should be kept away from light and moisture.
Volume of Distribution
Dilarof has a volume of distribution of 0.91 L/kg.
Half Life
The half-life of Dilarof is approximately 11 hours.
Clearance
Dilarof has an oral clearance of approximately 7.3 L/h.
Here you find in details version of Dilarof